Suspension, interfacial properties of suspended particles, settling in suspensions, formulation of flocculated and deflocculated suspensions. Emulsions and theories of emulsification, microemulsion and multiple emulsions; Stability of emulsions, preservation of emulsions, rheological properties of emulsions.
Hard gelatin capsules - a detailed studyTeny Thomas
The presentation involves a descriptive study on hard gelatin capsules which includes the production of the hard gelatin capsule shell, size of the capsules, capsule filling machines and the finishing techniques. The presentation also involves the special techniques of capsule formulation and the quality control tests of hard gelatin capsules
Suspension are biphasic liquids dosage form in which insoluble solid particulate are uniformly distributed in liquid phase which may be stabilized by inclusion of suspending agents.
I Omkar B. Tipugade , M-Pharm, Sem 4th , Department of Pharmaceutics , Shree Santkrupa College Of Pharmacy, Ghogaon. Today I published the hard gelatin & Soft Gelatin Capsule in brief .
Hard gelatin capsules - a detailed studyTeny Thomas
The presentation involves a descriptive study on hard gelatin capsules which includes the production of the hard gelatin capsule shell, size of the capsules, capsule filling machines and the finishing techniques. The presentation also involves the special techniques of capsule formulation and the quality control tests of hard gelatin capsules
Suspension are biphasic liquids dosage form in which insoluble solid particulate are uniformly distributed in liquid phase which may be stabilized by inclusion of suspending agents.
I Omkar B. Tipugade , M-Pharm, Sem 4th , Department of Pharmaceutics , Shree Santkrupa College Of Pharmacy, Ghogaon. Today I published the hard gelatin & Soft Gelatin Capsule in brief .
This Slide Contains A Brief Lecture On Suspensions and Its Types Based On The Factors Affecting The Preparation Of Dosage Form In The Field Of Pharmaceutics
A pharmaceutical suspension is a heterogeneous system in which finely divided solid particles are dispersed in a liquid medium. Unlike solutions, where solutes are completely dissolved, suspensions involve particles that are only partially soluble or insoluble in the liquid. These suspensions are commonly used in the pharmaceutical industry to deliver medications that may be poorly soluble or unstable in their pure form. The solid particles, often in the form of powders or crystals, are dispersed throughout the liquid phase, creating a stable mixture through the use of suspending agents or stabilizers. These agents prevent the settling of particles, ensuring uniform distribution and ease of redispersion upon shaking before administration. Pharmaceutical suspensions offer advantages in terms of flexibility in dosing and formulation, enabling the delivery of therapeutic agents in various forms such as oral liquids, injectables, or topical preparations, enhancing patient compliance and therapeutic efficacy. The formulation and stability of pharmaceutical suspensions require careful consideration of factors such as particle size, density, and the choice of stabilizers to maintain a consistent and reliable product.
Pharmaceutical Suspension Dosage Form (PPT)Prachi Pandey
A pharmaceutical suspension is a heterogeneous system in which finely divided solid particles are dispersed in a liquid medium. Unlike solutions, where solutes are completely dissolved, suspensions involve particles that are only partially soluble or insoluble in the liquid. These suspensions are commonly used in the pharmaceutical industry to deliver medications that may be poorly soluble or unstable in their pure form. The solid particles, often in the form of powders or crystals, are dispersed throughout the liquid phase, creating a stable mixture through the use of suspending agents or stabilizers. These agents prevent the settling of particles, ensuring uniform distribution and ease of redispersion upon shaking before administration. Pharmaceutical suspensions offer advantages in terms of flexibility in dosing and formulation, enabling the delivery of therapeutic agents in various forms such as oral liquids, injectables, or topical preparations, enhancing patient compliance and therapeutic efficacy. The formulation and stability of pharmaceutical suspensions require careful consideration of factors such as particle size, density, and the choice of stabilizers to maintain a consistent and reliable product.
Surfactants and their applications in pharmaceutical dosage formMuhammad Jamal
This presentation is very much helpful for the medical students,pharmacists, researchers and other health care providers. i hope it will provide important information regarding surfactants and their applications in pharmaceutical dosage forms.
Suspension is made of two phase system, consisting of a finely divided solid particles (Dispersed phase) distributed in a particular manner throughout another medium (Continuous phase).
This PPT contains enough information about the chapter SUSPENSION in Pharmaceutics, Which includes Definition, Classification, Route of Administration, Preparation Suspending Agents, Evaluation.
UNIT V
Mucoadhesive Delivery Systems:
Mechanism of bioadhesion, mucoadhesive materials, formulation and evaluation of Buccal and Nasal drug delivery systems.
I. INTRODUCTION
II. DEFINITIONS
III. TYPES OF DRUG MASTER FILES
IV. SUBMISSIONS TO DRUG MASTER FILES
V. AUTHORIZATION TO REFER TO A DRUG MASTER FILE
VI. PROCESSING AND REVIEWING POLICIES
VII. HOLDER OBLIGATIONS
IX. CLOSURE OF A DRUG MASTER FILE.
Introduction to Dissolution equipment's, Calibration of dissolution apparatus, Dissolution procedure development and validation, Dissolution method development for generic drug products.
Introduction and classification, anatomy of skin and factors affecting absorption, Formulation ,preparation, packaging, labeling and storage of ointments, Formulation, preparation, packaging, labeling and storage of jellies, creams, pastes.
Semisolid dosage forms: Definitions, classification, mechanisms and factors influencing dermal penetration of drugs. Preparation of ointments, pastes, creams and gels. Excipients used in semi solid dosage forms. Evaluation of semi solid dosages forms
Historical background and development of profession of pharmacy: History of profession of Pharmacy in India in relation to pharmacy education, industry and organization, Pharmacy as a career, Pharmacopoeias: Introduction to IP, BP, USP and Extra Pharmacopoeia.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. 4.Add Flocculating agent
& Structured vehicle
FORMULATION OF SUSPENSION:
Particles
1.Add Wetting Agent
Dispersion Medium
Uniform dispersion
of Deflocculated
Particles
2.Add Structured
vehicle
3.Add Flocculating
agent
Deflocculated Suspension
in Structured vehicle
Flocculated
Suspension
Flocculated
Suspension in
Structured
vehicle
3. Step-1: Dispersion of solids:
Water (solvent) + Insoluble solids (Hydrophobic) Difficult
to disperse.
Small particles adsorb air and float on solvent surface.
Dispersion can be done by
1. Water miscible Co-solvents = Alcohol, Glycerin, PEG
Floating particles + Glycerin removes air on surface,
forms a coat ↑Dispersion.
2. Wetting agents:
Surfactants ↓IFT, ↓Contact angle(90-00) ↑Dispersion.
(HLB= 7-9)
4. Step-2: Deflocculated Suspension in Structured vehicle:
Structured vehicles are the vehicles which exhibit
pseudo plastic/ plastic rheological behavior.
These also posses thixotropic behavior i.e., gel-sol-gel
transformation to improve physical stability of
suspension.
Structured vehicles are hydrocolloids, in low Conc.
absorb water, swell to give high viscosity.
They act as protective colloid to stabilize charge.
Ex: Non-ionic = MC, HPMC
Anionic = Sodium CMC, Carbopol.
Clays = Bentonite
5. Concentration of suspending agent depends on:
1. Viscosity of vehicle:
Vehicle (low ɳ) + High Conc. suspending agent
Vehicle (high ɳ) + low Conc. suspending agent
2. Amount of solid:
Oral= high solid content + high Conc. S.A (non-ionic)
Parenteral= low solid content + low Conc. S.A (0.5% W/V)
If clays are used add preservatives (2-5% W/V)
3. Particle Size:
Small size + low Conc. suspending agent
Large size + High Conc. suspending agent
4. Density of solids:
Structured vehicles + PVP/PEG/Sugars ↑ viscosity.
5. pH, Ionic strength.
6. Step-3: Flocculated Suspension:
Flocculating agent= electrolytes, surfactants, polymers.
1. Electrolytes:
All suspended particles same charge Repulsive forces
Add electrolytes of opposite chargeAttractive forcesFlocs
Bismuth sub nitrate(+) + water + WA Deflocculated
suspension + Monobasic potassium phosphate(-)
electrolyte Flocculated Suspension.
Flocculated Suspension + extra electrolyte all particles (-)
charged repulsions Deflocculated suspension
7. Zeta potential & Sedimentation:
Suspension Charge Sedimentation(Vu/Vo)
Deflocculated [+] Low- hard cake
flocculated [+][-] = neutral High
Deflocculated [-][+][-] = [-] Low-hard cake
Other examples:
Sulfamerazine (-)
and flocculating
agent AlCl3 (+)
8. Controlled floccullation:
Most dispersed particles posses charge depending on
pH of the system.
The charge should be adjusted to zero and adjust pH to
make flocculated suspension in non-caking zone with
optimum zeta potential .
13. Physical stability of suspension:
Physical stability is defined as a condition in which the
particles remain uniformly distributed throughout
dispersion with out any signs of sedimentation.
Even if particles settle they should be easily
redispersed with moderate amount of shaking.
SUSPENSION EVALUATIONS:
1. Sedimentation volume (F)
2. Degree of flocculation (β)
3. Redispersibility.
14. 1. Sedimentation Volume (F):
F is dimension less quantity, value ranges from 1-0.
F value is proportional to stability
If F=1, Vu=Vo, ideal suspension
If F=0, Vu=0, total instability.
This evaluation is useful for
1. Selection of better suspension
2. Identifying suitable suspending agent
3. Obtaining optimum concentration of suspending agent.
15.
16. 2. Degree of flocculation (β)
β is dimension less quantity, value ranges from 1-infinity.
β value is proportional to stability
If β =1, F=Fα, minimum value indicating system is
defloccuated.
The sedimentation volume of deflocculated system is less
than that of flocculated system.
17. 3. Redispersibility:
Mechanical shaker device simulating human motion.
Suspension in 100 ml measuring cylinder stored to
sediment placed in machine, rotated 3600 at 20 RPM
sediment redispersed time/no. of rotations NOTED.
Less time/ less rotations= disperse stable suspension
More time/ more rotations= disperse unstable
suspension.
18. Rheological considerations:
Important in manufacturing, storage, administration.
Dispersion medium should have thixotropic behavior -
plastic/ pseudoplastic (gel-sol-gel)
Preformulation studies:
Performed to evaluate vehicle for optimum viscosity.
Method:
1. Vehicles mixed with various S.A/ various Conc. Of same
S.A
2. Shear stress noted form lower to higher rates of shear.
3. Obtained hysteresis loop is compared with standard
product graph.
20. Brookfield viscometer:
Best suitable for studying settling in
suspensions
Contains helipathic stand with “T”
shaped spindle, moves in helix
manner up-down.
As suspension exhibits thixotropic
behavior
Initial GEL show resistance high dial
reading
Next SOL less resistance low dial
reading.
A good suspension has less rate of
decrease in dial reading in Gel SOL
transformation.
21. 1. The results indicate how particles settle with respect to
time.
2. The technique provides information at which level the
floccule network is greater due to aggregation.
3. Effect of aging on storage can be evaluated.
23. Advanatges/Applications of Suspensions:
1. Stability:
Drug in solution is unstable (hydrolysis)
Suspension = insoluble drug STABLE.
Ex: Procaine Penicillin-G
2. Choice of solvent:
Drug is insoluble in water,
Solvent other than water is not acceptable prepare
Suspension.
Ex: Corticosteroid Injection
3. Taste masking:
Suspension = (Unpleasant tasted Drug + Flavour/Sweetners)
Ex: Chloramphenicol Palmitate.
24. 4. Prolonged drug action:
Insoluble drug Reservoir drug released for long period
Ex: Procaine Penicillin –G
5. Bioavailability:
Suspensions have high bioavailability than Tab, Cap because
of large surface area, high dissolution rate.
Ex: Antacid Suspension acts faster than antacid tablets.
25.
26. • DEF:
A thermodynamically unstable system consisting of at least
two immiscible liquid phases, one of which is dispersed
as globules in the other liquid phase.
• Emulsion is stabilized by an emulsifying agent.
• Globule diameter 0.1- 100µm
Ex: Milk, ice cream, paints, lotions of low viscosity to
ointments, creams which are semi-solids
Classification:
1. Basing on dispersed phase - 2 Types o/w and w/o
Medicinal emulsions are mostly o/w type.
2. Basing on globule size – 2 types
Microemulsions (0.01µm)
Fine emulsions (0.25-25 µm)
27.
28. EMULSIFYING AGENT
Functions:
1. To prevent coalescence of dispersed globules.
2. To reduce IFT between polar and non-polar solvents.
Surfactants:
HLB (3-8) W/O emulsifying agent- Spans
HLB (8-16) O/W emulsifying agent- Tweens.
Brancrofts Rule: States that though emulsifying agent has
affinity towards polar and non-polar liquids, they have
preferential solubility in one of the liquid which becomes
continuous phase.
Combination of E.A imparts better stability
Ionic type of E.A not preferred for internal use as they
interact with biomembranes and effect cell functioning.
Natural E.A show batch-batch variation & microbial
growth.
30. Mechanisms of emulsion formation
Emulsifying agent Forms film on dispersed globules.
1. Monomolecular adsorption film Surfactants-
Spans, Tweens.
2. Multimolecular adsorption film Hydrophilic
colloids – Acacia, Gelatin.
3. Solid particle Adsorption Finely divided solids-
Bentonite, Veegum.
31. 1. Monomolecular adsorption film:
Surfactants form monomolecular film at oil-water
interface and cover the globule.
The film should be strong, elastic, flexible to reform
when broken.
Emulsion stability depends on physical, chemical,
mechanical properties of film.
Oil soluble & water soluble surfactant combination
interactions forms complex & strong film.
Ionic surfactants develop repulsive forces between
globules to prevent Coalescence.
Nonionic surfactants forms thick film on globule to
prevent Coalescence.
32. 1. Sodium + Cholesterol strong, strong Good
cetyl sulphate interaction film emulsion
2. Sodium + Oleyl alcohol less weak film Poor
cetyl sulphate interactions emulsion
3. Sodium + Cetyl alcohol less complex Poor emulsion
oleate film
34. 3. Solid particle Adsorption:
Finely divided solid particles adsorb at oil-water
interface to form rigid film.
Film act as mechanical barrier to prevent coalescence.
o/w veegum, bentonite
w/o bentonite
The stability of emulsion depends on the finer state of
sub-division of solid particles, irregular surface &
charge on surface.
35. Interfacial properties in emulsion:
Surfactants reduce IFT leading to globule formation and
increase in surface free energy.
ΔG = γ 0/w ΔA
γ 0/w = interfacial tension between oil & water
ΔA = increase in surface area.
With increase in surface free energy system becomes
unstable, to stabilize ΔG = 0.
1. Method-A:
ΔA =0 means regrouping of particles phase seperation.
2. Method-B:
γ 0/w =0. This is not possible, but γ 0/w can be reduced by
adding surfactants.
36. THEORIES OF EMULSIFICATION:
Many theories have been advanced to account for the way
or means by which the emulsion is stabilized by the
emulsifier.
At the present time no theory has been postulated that
seems to apply universally to all emulsions.
1) Electric Double Layer Theory.
2) Phase Volume Theory.
3) Hydration Theory of Emulsions
4) Oriented wedge theory.
5) Adsorbed Film and Interfacial tension Theory
6) Surface tension theory.
37. 1) Electric Double Layer Theory:
The oil globules in a O/W emulsion carry a negative charge.
The water ionizes so that both hydrogen and hydroxyl
ions are present. The negative charge on the oil may
come from adsorption of the OH ions. These adsorbed
hydroxyl ions form a layer around the oil globules.
A second layer of oppositely charged ions forms a layer in
the liquid outside the layer of negative ions.
These two layers of oppositely charged ions are known as
the Helmholtz double layer.
They are not confined to emulsions but accompany all
boundary phenomena. The electric charge is a factor in
all emulsions, even those stabilized with emulsifying
agents
38. 2) Phase Volume Theory:
If spheres of the same diameter are packed as closely as
possible, one sphere will touch 12 others and the volume
the spheres occupy is about 74 per cent of the total
volume.
Thus if the spheres or drops of the dispersed phase remain
rigid it is possible to disperse 74 parts of the dispersed
phase in the continuous phase; but if the dispersed phase
is increased to more than 74 parts of the total volume, a
reversal of the emulsion will occur.
However, the dispersed phase does not remain rigid in shape
but the drops flatten out where they come in contact with
each other.
39. 3) Hydration Theory of Emulsions:
• Fischer and Hooker state that hydrated colloids make
the best emulsifiers.
• Fischer states the emulsifying agent, by which a
permanent emulsion is obtained, invariably "proves to
be a hydrophilic colloid when W/O emulsions are
concerned (a lyophilic colloid of some sort when other
than aqueous mixtures are under consideration). Put
another way, oil cannot permanently be beaten into
water, but only into a colloid hydrate."
• Fischer and Hooker have found albumin, casein, and
gelatin to be good emulsifying agents.
40. 4) Oriented wedge theory:
• This theory deals with formation of monomolecular
layers of emulsifying agent curved around a droplet of the
internal phase of the emulsion.
Example:
• In a system containing 2 immiscible liquids, emulsifying
agent would be preferentially soluble in one of the phases
and would be embedded in that phase.
• Hence an emulsifying agent having a greater hydrophilic
character will promote o/w emulsion and vice-versa.
• Sodium oleate is dispersed in water and not oil. It forms a
film which is wetted by water than by oil. This leads the
film to curve so that it encloses globules of oil in water.
41. 5) Adsorbed film and interfacial tension theory:
Lowering interfacial tension is one way to decrease the
free surface energy associated with the formation of
droplets. Assuming the droplets are spherical,
ΔF= 6 γ V
D
V= volume of the dispersed phase in ml, d is the mean
diameter of the particles.
γ = interfacial tension
It is desirable that:
The surface tension be reduced below 10dynes/cm by the
emulsifier and Be absorbed quickly.
42. 6) Surface Tension Theory:
• A drop of liquid forms a spherical shape which gives it
the smallest surface area per unit volume
• When 2 drops come together to form a bigger drop-
gives lesser surface area. Also called surface tension at
air-liquid interface
• Surface Tension- Force that has to be applied parallel to
the surface of liquid to counterbalance exactly the
internal inward forces that tend to pull the molecule
together.
• When there are two immiscible liquids-it is called
interfacial tension.
44. Instability Factors Prevention
1. FLOCCULATION:
Globules come
close to each other
to form
aggregates.
1. Ununiform
globule size
distribution
2. Opposite charge
on globule
surface
3. Low viscosity of
external
medium.
1. Unifrom sized
globules
2. Use same
charged ionic
E.A, electrolytes
3. Viscosity
improving
agents-
hydrocolloids.
45. Instability Factors Prevention
2. CREAMING:
Concentration of
globules at
top/bottom of
emulsion
1. Globule size
2. Viscosity of
external
medium
3. Differences in
density of oil-
water (aq>oil)
1. Homogenization
- Unifrom sized
globules
2. Thickening
agents to improve
viscosity
3. Reducing
density differences
(Bromoform + oil)
• Creaming is a reversible process/ temporary change and
shaking redisperses globules as E.A coating is present
• Creaming is detected by differences in colour shades.
46. Instability Factors Prevention
3. COALESCENCE:
Few globules fuse
to form bigger
globules.
Emulsifier film is
destroyed.
1. Insufficient amount of
E.A
2. Altered partitioning of
E.A
3. Incompatability
between E.A
4. Phase-volume ratio
greater than 74%
NO, this is
permanent
change.
4. BREAKING:
Complete
separation of oil &
aqueous phases.
1. Unnoticed Coalescence. NO, this is
permanent
change.
47. Instability Factors
5. PHASE
INVERSION:
Change in
emulsion
from o/w to
w/o or
viceversa
1. Change in chemical nature of E.A:
Sodium sterate (water soluble) o/w emul
Sodium sterate + CaCl2 Calcium sterate
Calcium sterate (oil soluble) w/o emul
2. Altering phase-volume ratio:
o/w emul + oil w/o emul + water o/w
This method should be properly controlled
other wise leads to phase inversion.
48. Factors to improve physical stability:
Brownian motion theory, stokes law provides 9 factors.
1. Globule size
2. Globule size distribution
3. Viscosity
4. Phase-volume ratio
5. Charge on Electrical Double Layer
6. Physical properties of interface
7. Densities of phases
8. Temperature fluctuations
9. Experimental techniques.
49. 1. Globule size:
Globule diameter ↓1/2 then creaming ↓ 4 times.
Industrial size reduction = Colloidal mill
Maximum stability is by Optimum globule size
Globule size (5µ) Brownian motion = NO Creaming.
Micro emulsion (0.01µ) = NO Creaming.
2. Globule size distribution:
Uniform, mono size = Stability
Ununifrom size = small globule settle in gaps of large
globules Coalescence.
50. 3. Viscosity:
High viscosity NO sedimentation, NO Brownian motion &
administration problems.
Optimum viscosity Good stability.
Viscosity improving agents
o/w= taragacnath CMC
w/o= long chain fatty acids, bees wax, alcohols, stearic acid.
4. Phase- volume ratio:
This is relative volume of water & oil in emulsion.
Medical emulsions (oil: water) = 50:50
In 50% oil globules 48% is porosity & 52% is globules
Critical point: is defined as concentration of internal phase
above which the E.A can not produce a stable emulsion of
desired type.
Critical point (74%)+ addition Coalescence of globules.
51. 5. Charge of electrical double layer:
Ionic E.A form coat on globule Repulsive forces NO
Flocculation.
Charge on EDL depends on pH and important for Ionic E.A
6. Physical properties of interface:
Interface of Oil-Water E.A Film STRONG (NO
Coalescence), ELASTIC (reform on breakage)
Film strength depends on pH. Optimum pH Stability.
7. Densities of phases: (Aq >Oil)
Aq = Oil prevent Creaming.
Oil + Brominated oil Oil density ↑ (But not practiced)
52. 8. Temperature fluctuations:
High temperature
1. Effect partitioning characteristics of E.A instability
2. Chemical degradation of drug instability
3. Water evaporate instability
Low temperature
Aq. pahse = Ice Crystals Rupture E.A film Coalescence.
9. Experimental techniques:
Poor experimental techniques incomplete emulsification
instability
All preparation steps should be carefully followed.
53. Evaluation of physical stability of emulsions:
Stable emulsion should retain initial properties during
storage until usage.
Chemical instability:
Degradation of drug, E.A, preservative etc.,
Physical instability:
Flocculation, creaming, coalescence, phase separation,
phase inversion.
Evaluation of Emulsions:
1. Extent of phase separation
2. Globule size distribution
3. Centrifugation – Accelerated stability study
4. Microwave irradiation
54. 1. Extent of phase separation:
Suitable for poorly formed, rapidly breaking emulsions.
This is quick method, visible after manufacturing.
2. Globule size distribution:
Optical microscopy measures globule diameter.
Unstable emulsion Small globules (1st day) large
globules (after few days)
Globule size should not be measured immediately after
manufacturing, because of active coalescence stage
(stress removal).
55. 3.Centrifugation – Accelerated stability study:
Flocculation, creaming, phase separation is slow process.
For fast testing stress is induced by centrifugation (2000-3000
rpm) Phase separation Depth of oil phase is
measured.
Induction period-
Time required for stable emulsion for oil separation.
56. 4. Microwave irradiation:
Emulsion in beaker Microwave irradiation (top-bottom)
measure temperature on Top & Bottom.
Stable emulsion less difference b/o high transmittance.
Unstable emulsion high difference b/o low transmittance.
57. PRESERVATION OF EMULSION:
Emulsion + Preservative Oral (No microorganisms),
Parenteral (Sterile)
Microorganisms destroy gums, proteins, instability.
(fungi, bacteria, yeast) carbohydrates,
Presevatives:- benzoic acid, sodium benzoate, methyl
paraben, propyl paraben etc.,
Factors for selection of preservative:
1. Aqueous phase:
Bacteria grow in water, interface Water soluble preservative
2. Volume fraction of aqueous phase:
o/w emul= high aq. Phase high Conc. Preservative.
w/o emul= low aq. Phase low conc. Preservative.
3. pH of aqueous phase:
Adjust pH Preservative undissociated form kill M.O easy
58. Preservative should be used in optimum concentration
for maximum effect.
[HA]w = concentration of undissociated acid in aq. phase
C = total concentration of acid
K = partition coefficient of acid
q = volume ratio of oil to aq. Phase
Ka = dissociation constant of acid
[H30+] = concentration of [H30+] ions in acid
59. Rheological properties of emulsion:
1. Removal of emulsion from bottle/tube
2. Flow of emulsion through hypodermic needle
3. Spreadability of an emulsion on skin
4. Stress induced flow changes during manufacturing.
Optimum viscosity gives maximum stability.
Phase-volume
ratio
Type of flow Viscosity measurement
Dilute emul- 5% Newtonian Single point viscometer
Concentrated
emul- 50%
Pseudoplastic Multiple point viscometer-
Cone & plate,
Cup & bobConcentrated
emul- 74%
Plastic
60. Preparation of emulsion:
1. Selection of oil phase
Fixed, mineral, volatile oils oxidation Add Anti-Oxidants
If oil is dispersed phase phase volume ↓ 25%
2. Selection of aqueous phase:
Adjust pH, Add preservatives, organoleptic additives.
3. Selection of Emulsifying agent:
Selected basing on type of emulsion (o/w, w/o), HLB, Use
(internal, external). Optimum concentration is 2%.
4. Emulsion preparation:
Small scale:- Mortar & pestle
1. Wet gum method (English method)
2. Dry gum method (Continental method)
3. Bottle method.
Large scale:- Colloidal mill
62. 1.Mask the unpleasant taste:
Unpleasant tasted drug globules in emulsion
Ex: laxatives, vitamin-A
2. Economical:
Expensive solvents are used to dissolve lipids.
In emulsion lipids are dispersed in water (cheaper).
3. Improved bioavailability:
Absorption of drugs is faster & better in emulsion
Ex: griseofulvin corn oil-water emulsion > griseofulvin tablets
4. Sustained release medication:
Water soluble antigen dispersed in oil o/w emul
Injected in body Depots in muscle slow drug release
Multiple emulsions (o/w/o) (w/o/w) give sustained release
63. 5. Nutritional supplement:
Terminally ill patients are given nutrition parenterally.
Emulsion oil phase (fats) ,Aq. phase (nutrients)
6. Diagnostic purpose:
radio-opaque emulsions are used in X-ray exam
7. Topical use:
Concentrated emulsion semi-solids.
Ex: cold cream, vanishing cream, benzyl benzoate etc.,